940 SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE HCV POLYMERASE INHIBITOR VCH-222 FOLLOWING SINGLE DOSE ADMINISTRATION IN HEALTHY VOLUNTEERS AND ANTIVIRAL ACTIVITY IN HCV-INFECTED INDIVIDUALS
C. Cooper, R. Larouche, B. Bourgault, N. Chauret, L. ProulxТом:
50
Рік:
2009
Мова:
english
DOI:
10.1016/s0168-8278(09)60942-9
Файл:
PDF, 48 KB
english, 2009